A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

I.M. Lips; C.H. van Gils; A.N.T.J. Kotte; M.E. van Leerdam; S.P.G. Franken; U.A. van der Heide; M. van Vulpen

A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

Translated title of the contribution: A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

I.M. Lips, C.H. van Gils, A.N.T.J. Kotte, M.E. van Leerdam, S.P.G. Franken, U.A. van der Heide, M. van Vulpen

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy
Original language	Undefined/Unknown
Pages (from-to)	653-660
Number of pages	8
Journal	International Journal of Radiation Oncology Biology Physics
Volume	83
Issue number	2
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22099039

Cite this

Lips, I. M., van Gils, C. H., Kotte, A. N. T. J., van Leerdam, M. E., Franken, S. P. G., van der Heide, U. A., & van Vulpen, M. (2012). A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. International Journal of Radiation Oncology Biology Physics, 83(2), 653-660. http://www.ncbi.nlm.nih.gov/pubmed/22099039

@article{bf529178c93543b0b79f66e9a578b2f5,

title = "A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy",

author = "I.M. Lips and {van Gils}, C.H. and A.N.T.J. Kotte and {van Leerdam}, M.E. and S.P.G. Franken and {van der Heide}, U.A. and {van Vulpen}, M.",

year = "2012",

language = "Undefined/Unknown",

volume = "83",

pages = "653--660",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier",

number = "2",

}

Lips, IM, van Gils, CH, Kotte, ANTJ, van Leerdam, ME, Franken, SPG, van der Heide, UA & van Vulpen, M 2012, 'A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy', International Journal of Radiation Oncology Biology Physics, vol. 83, no. 2, pp. 653-660. <http://www.ncbi.nlm.nih.gov/pubmed/22099039>

A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. / Lips, I.M.; van Gils, C.H.; Kotte, A.N.T.J. et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 83, No. 2, 2012, p. 653-660.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

AU - Lips, I.M.

AU - van Gils, C.H.

AU - Kotte, A.N.T.J.

AU - van Leerdam, M.E.

AU - Franken, S.P.G.

AU - van der Heide, U.A.

AU - van Vulpen, M.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0360-3016

VL - 83

SP - 653

EP - 660

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 2

ER -